Pharmacogenetics of Debrisoquine and its Use as a Marker For CYP2D6 Hydroxylation Capacity

DOI Web Site 2 Citations
  • Adrián LLerena
    CICAB, Clinical Research Centre, Extremadura University Hospital and Medical School, Spain.
  • Pedro Dorado
    CICAB, Clinical Research Centre, Extremadura University Hospital and Medical School, Spain.
  • Eva M Peñas-Lledó
    CICAB, Clinical Research Centre, Extremadura University Hospital and Medical School, Spain.

Journal

  • Pharmacogenomics

    Pharmacogenomics 10 (1), 17-28, 2008-12-23

    Informa UK Limited

Citations (2)*help

See more

Details 詳細情報について

Report a problem

Back to top